Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
Endosonographic features of unicentric Castleman Disease.

Endoscopic ultrasound

Panagiotakopoulos D, Mouchtouris A, Zarakostas M, Rontogianni D, Athanasiadou P.
PMID: 26425506
Endosc Ultrasound. 2014 Apr;3:S10-1.

BACKGROUND: Castleman disease (CD) is a rare lymphoproliferative disorder most frequently occurring in the mediastinum. Peripancreatic forms are less frequent. Few cases of endoscopic ultrasonography-fine-needle aspiration (EUS-FNA) findings of this lesion have been reported, where no real-time tissue elastography...

Cite
Panagiotakopoulos D, Mouchtouris A, Zarakostas M, et al. Endosonographic features of unicentric Castleman Disease. Endosc Ultrasound. 2014;3:S10-1
Panagiotakopoulos, D., Mouchtouris, A., Zarakostas, M., Rontogianni, D., & Athanasiadou, P. (2014). Endosonographic features of unicentric Castleman Disease. Endoscopic ultrasound, 3S10-1.
Panagiotakopoulos, D, et al. "Endosonographic features of unicentric Castleman Disease." Endoscopic ultrasound vol. 3 (2014): S10-1.
Panagiotakopoulos D, Mouchtouris A, Zarakostas M, Rontogianni D, Athanasiadou P. Endosonographic features of unicentric Castleman Disease. Endosc Ultrasound. 2014 Apr;3:S10-1. PMID: 26425506; PMCID: PMC4569904.
Copy Download .nbib Format: NLM
Medicinal plants for helminth parasite control: facts and fiction.

Animal : an international journal of animal bioscience

Athanasiadou S, Githiori J, Kyriazakis I.
PMID: 22444894
Animal. 2007 Oct;1(9):1392-400. doi: 10.1017/S1751731107000730.

The use of medicinal plants for the prevention and treatment of gastro-intestinal parasitism has its origin in ethnoveterinary medicine. Although until recently the majority of the evidence on the antiparasitic activity of medicinal plants was anecdotal and lacked scientific...

Cite
Athanasiadou S, Githiori J, Kyriazakis I. Medicinal plants for helminth parasite control: facts and fiction. Animal. 2007;1(9):1392-400doi: 10.1017/S1751731107000730.
Athanasiadou, S., Githiori, J., & Kyriazakis, I. (2007). Medicinal plants for helminth parasite control: facts and fiction. Animal : an international journal of animal bioscience, 1(9), 1392-400. https://doi.org/10.1017/S1751731107000730
Athanasiadou, S, et al. "Medicinal plants for helminth parasite control: facts and fiction." Animal : an international journal of animal bioscience vol. 1,9 (2007): 1392-400. doi: https://doi.org/10.1017/S1751731107000730
Athanasiadou S, Githiori J, Kyriazakis I. Medicinal plants for helminth parasite control: facts and fiction. Animal. 2007 Oct;1(9):1392-400. doi: 10.1017/S1751731107000730. PMID: 22444894.
Copy Download .nbib Format: NLM
Expression of ras p21 and myc p64 oncoproteins in imprint smears of lung-cancer.

Oncology reports

Orphanidou D, Athanasiadou P, Toumbis M, Rasidakis A, Petrakakou E, Kyrkou K, Jordanoglou J.
PMID: 21597773
Oncol Rep. 1995 Jul;2(4):549-52. doi: 10.3892/or.2.4.549.

The expression of ras p21 and myc p64 was examined in imprint smears of 52 patients with lung cancer and 44 patients with benign disorders, by immunochemistry. Imprint smears were-taken from fresh bronchial biopsies during diagnostic bronchoscopy. Both ras...

Cite
Orphanidou D, Athanasiadou P, Toumbis M, et al. Expression of ras p21 and myc p64 oncoproteins in imprint smears of lung-cancer. Oncol Rep. 1995;2(4):549-52doi: 10.3892/or.2.4.549.
Orphanidou, D., Athanasiadou, P., Toumbis, M., Rasidakis, A., Petrakakou, E., Kyrkou, K., & Jordanoglou, J. (1995). Expression of ras p21 and myc p64 oncoproteins in imprint smears of lung-cancer. Oncology reports, 2(4), 549-52. https://doi.org/10.3892/or.2.4.549
Orphanidou, D, et al. "Expression of ras p21 and myc p64 oncoproteins in imprint smears of lung-cancer." Oncology reports vol. 2,4 (1995): 549-52. doi: https://doi.org/10.3892/or.2.4.549
Orphanidou D, Athanasiadou P, Toumbis M, Rasidakis A, Petrakakou E, Kyrkou K, Jordanoglou J. Expression of ras p21 and myc p64 oncoproteins in imprint smears of lung-cancer. Oncol Rep. 1995 Jul;2(4):549-52. doi: 10.3892/or.2.4.549. PMID: 21597773.
Copy Download .nbib Format: NLM
Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis.

Annals of gastroenterology

Paschos P, Katsoula A, Giouleme O, Sarigianni M, Liakos A, Athanasiadou E, Bekiari E, Tsapas A.
PMID: 30174394
Ann Gastroenterol. 2018 Sep-Oct;31(5):572-582. doi: 10.20524/aog.2018.0276. Epub 2018 May 10.

BACKGROUND: The aim of the study was to assess the efficacy and safety of tofacitinib and its impact on quality of life in patients with moderate-to-severe ulcerative colitis.METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials...

Cite
Paschos P, Katsoula A, Giouleme O, et al. Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis. Ann Gastroenterol. 2018;31(5):572-582doi: 10.20524/aog.2018.0276.
Paschos, P., Katsoula, A., Giouleme, O., Sarigianni, M., Liakos, A., Athanasiadou, E., Bekiari, E., & Tsapas, A. (2018). Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis. Annals of gastroenterology, 31(5), 572-582. https://doi.org/10.20524/aog.2018.0276
Paschos, Paschalis, et al. "Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis." Annals of gastroenterology vol. 31,5 (2018): 572-582. doi: https://doi.org/10.20524/aog.2018.0276
Paschos P, Katsoula A, Giouleme O, Sarigianni M, Liakos A, Athanasiadou E, Bekiari E, Tsapas A. Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis. Ann Gastroenterol. 2018 Sep-Oct;31(5):572-582. doi: 10.20524/aog.2018.0276. Epub 2018 May 10. PMID: 30174394; PMCID: PMC6102462.
Copy Download .nbib Format: NLM
Expression of IGF-I, TGF-alpha and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer.

Oncology reports

Orphanidou D, Athanasiadou P, Toumbis M, Petrakakou E, Dimakou K, Kyrkou K, Rasidakis A, Jordanoglou J.
PMID: 21594318
Oncol Rep. 1996 Jan;3(1):75-80. doi: 10.3892/or.3.1.75.

The expression of insulin-like growth factor-I (IGF-I), transforming growth factor-alpha (TGF-alpha) and p53 protein was examined in bronchial biopsy imprint smears of patients with primary lung cancer and benign lung disorders, by immunohistochemistry. Of the 44 malignant imprint smears,...

Cite
Orphanidou D, Athanasiadou P, Toumbis M, et al. Expression of IGF-I, TGF-alpha and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer. Oncol Rep. 1996;3(1):75-80doi: 10.3892/or.3.1.75.
Orphanidou, D., Athanasiadou, P., Toumbis, M., Petrakakou, E., Dimakou, K., Kyrkou, K., Rasidakis, A., & Jordanoglou, J. (1996). Expression of IGF-I, TGF-alpha and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer. Oncology reports, 3(1), 75-80. https://doi.org/10.3892/or.3.1.75
Orphanidou, D, et al. "Expression of IGF-I, TGF-alpha and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer." Oncology reports vol. 3,1 (1996): 75-80. doi: https://doi.org/10.3892/or.3.1.75
Orphanidou D, Athanasiadou P, Toumbis M, Petrakakou E, Dimakou K, Kyrkou K, Rasidakis A, Jordanoglou J. Expression of IGF-I, TGF-alpha and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer. Oncol Rep. 1996 Jan;3(1):75-80. doi: 10.3892/or.3.1.75. PMID: 21594318.
Copy Download .nbib Format: NLM
Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?.

HemaSphere

Papalexandri A, Saloum R, Touloumenidou T, Papathanasiou M, Lalayanni C, Baldoumi E, Demosthenous C, Zerva P, Koutra MG, Athanasiadou A, Anagnostopoulos A.
PMID: 31723795
Hemasphere. 2018 Nov 12;2(6):e157. doi: 10.1097/HS9.0000000000000157. eCollection 2018 Dec.

No abstract available.

Cite
Papalexandri A, Saloum R, Touloumenidou T, et al. Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?. Hemasphere. 2018;2(6):e157doi: 10.1097/HS9.0000000000000157.
Papalexandri, A., Saloum, R., Touloumenidou, T., Papathanasiou, M., Lalayanni, C., Baldoumi, E., Demosthenous, C., Zerva, P., Koutra, M. G., Athanasiadou, A., & Anagnostopoulos, A. (2018). Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?. HemaSphere, 2(6), e157. https://doi.org/10.1097/HS9.0000000000000157
Papalexandri, Apostolia, et al. "Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?." HemaSphere vol. 2,6 (2018): e157. doi: https://doi.org/10.1097/HS9.0000000000000157
Papalexandri A, Saloum R, Touloumenidou T, Papathanasiou M, Lalayanni C, Baldoumi E, Demosthenous C, Zerva P, Koutra MG, Athanasiadou A, Anagnostopoulos A. Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?. Hemasphere. 2018 Nov 12;2(6):e157. doi: 10.1097/HS9.0000000000000157. eCollection 2018 Dec. PMID: 31723795; PMCID: PMC6745958.
Copy Download .nbib Format: NLM
Peptide-Decorated DNA Nanostructures Promote Site-Specific Hydroxyapatite Growth.

ACS applied materials & interfaces

Danesi AL, Athanasiadou D, Aderinto AO, Rasie P, Chou LYT, Carneiro KMM.
PMID: 34957820
ACS Appl Mater Interfaces. 2022 Jan 12;14(1):1692-1698. doi: 10.1021/acsami.1c19271. Epub 2021 Dec 27.

The guiding principle for mineralized tissue formation is that mineral growth occurs through the interaction of Ca

Cite
Danesi AL, Athanasiadou D, Aderinto AO, et al. Peptide-Decorated DNA Nanostructures Promote Site-Specific Hydroxyapatite Growth. ACS Appl Mater Interfaces. 2021;14(1):1692-1698doi: 10.1021/acsami.1c19271.
Danesi, A. L., Athanasiadou, D., Aderinto, A. O., Rasie, P., Chou, L. Y. T., & Carneiro, K. M. M. (2022). Peptide-Decorated DNA Nanostructures Promote Site-Specific Hydroxyapatite Growth. ACS applied materials & interfaces, 14(1), 1692-1698. https://doi.org/10.1021/acsami.1c19271
Danesi, Alexander L, et al. "Peptide-Decorated DNA Nanostructures Promote Site-Specific Hydroxyapatite Growth." ACS applied materials & interfaces vol. 14,1 (2022): 1692-1698. doi: https://doi.org/10.1021/acsami.1c19271
Danesi AL, Athanasiadou D, Aderinto AO, Rasie P, Chou LYT, Carneiro KMM. Peptide-Decorated DNA Nanostructures Promote Site-Specific Hydroxyapatite Growth. ACS Appl Mater Interfaces. 2022 Jan 12;14(1):1692-1698. doi: 10.1021/acsami.1c19271. Epub 2021 Dec 27. PMID: 34957820.
Copy Download .nbib Format: NLM
Nutritional Pearls: Diet and Rheumatoid Arthritis.

Mediterranean journal of rheumatology

Athanassiou P, Athanassiou L, Kostoglou-Athanassiou I.
PMID: 33163864
Mediterr J Rheumatol. 2020 May 15;31(3):319-324. doi: 10.31138/mjr.31.3.319. eCollection 2020 Sep.

Various studies have investigated the effect of diet on rheumatoid arthritis (RA) as a complimentary treatment along with standard drug therapy. Various types of diet have been investigated. Fasting, the Mediterranean diet, the Cretan Mediterranean diet, vegetarian diet, an...

Cite
Athanassiou P, Athanassiou L, Kostoglou-Athanassiou I. Nutritional Pearls: Diet and Rheumatoid Arthritis. Mediterr J Rheumatol. 2020;31(3):319-324doi: 10.31138/mjr.31.3.319.
Athanassiou, P., Athanassiou, L., & Kostoglou-Athanassiou, I. (2020). Nutritional Pearls: Diet and Rheumatoid Arthritis. Mediterranean journal of rheumatology, 31(3), 319-324. https://doi.org/10.31138/mjr.31.3.319
Athanassiou, Panagiotis, et al. "Nutritional Pearls: Diet and Rheumatoid Arthritis." Mediterranean journal of rheumatology vol. 31,3 (2020): 319-324. doi: https://doi.org/10.31138/mjr.31.3.319
Athanassiou P, Athanassiou L, Kostoglou-Athanassiou I. Nutritional Pearls: Diet and Rheumatoid Arthritis. Mediterr J Rheumatol. 2020 May 15;31(3):319-324. doi: 10.31138/mjr.31.3.319. eCollection 2020 Sep. PMID: 33163864; PMCID: PMC7641018.
Copy Download .nbib Format: NLM
Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation.

HemaSphere

Gavriilaki E, Sakellari I, Chatzikonstantinou T, Mallouri D, Batsis I, Vardi A, Bousiou Z, Koravou EE, Masmanidou M, Touloumenidou T, Papalexandri A, Athanasiadou A, Yannaki E, Anagnostopoulos A.
PMID: 33324949
Hemasphere. 2020 Dec 09;5(1):e487. doi: 10.1097/HS9.0000000000000487. eCollection 2021 Jan.

No abstract available.

Cite
Gavriilaki E, Sakellari I, Chatzikonstantinou T, et al. Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation. Hemasphere. 2020;5(1):e487doi: 10.1097/HS9.0000000000000487.
Gavriilaki, E., Sakellari, I., Chatzikonstantinou, T., Mallouri, D., Batsis, I., Vardi, A., Bousiou, Z., Koravou, E. E., Masmanidou, M., Touloumenidou, T., Papalexandri, A., Athanasiadou, A., Yannaki, E., & Anagnostopoulos, A. (2021). Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation. HemaSphere, 5(1), e487. https://doi.org/10.1097/HS9.0000000000000487
Gavriilaki, Eleni, et al. "Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation." HemaSphere vol. 5,1 (2021): e487. doi: https://doi.org/10.1097/HS9.0000000000000487
Gavriilaki E, Sakellari I, Chatzikonstantinou T, Mallouri D, Batsis I, Vardi A, Bousiou Z, Koravou EE, Masmanidou M, Touloumenidou T, Papalexandri A, Athanasiadou A, Yannaki E, Anagnostopoulos A. Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation. Hemasphere. 2020 Dec 09;5(1):e487. doi: 10.1097/HS9.0000000000000487. eCollection 2021 Jan. PMID: 33324949; PMCID: PMC7732269.
Copy Download .nbib Format: NLM
Anti-synthetase syndrome presenting with interstitial lung disease.

Mediterranean journal of rheumatology

Athanassiou P, Kostopoulos M, Tzanavari A, Spyridis A, Kostoglou-Athanassiou I.
PMID: 32185286
Mediterr J Rheumatol. 2017 Dec 22;28(4):212-216. doi: 10.31138/mjr.28.4.212. eCollection 2017 Dec.

Anti-synthetase syndrome is an idiopathic inflammatory myopathy characterized by interstitial lung involvement, arthritis, Raynaud's phenomenon, mechanic's hands and fever. The case of anti-synthetase syndrome in a young female is reported. The patient presented with interstitial lung disease, initially subclinical...

Cite
Athanassiou P, Kostopoulos M, Tzanavari A, et al. Anti-synthetase syndrome presenting with interstitial lung disease. Mediterr J Rheumatol. 2017;28(4):212-216doi: 10.31138/mjr.28.4.212.
Athanassiou, P., Kostopoulos, M., Tzanavari, A., Spyridis, A., & Kostoglou-Athanassiou, I. (2017). Anti-synthetase syndrome presenting with interstitial lung disease. Mediterranean journal of rheumatology, 28(4), 212-216. https://doi.org/10.31138/mjr.28.4.212
Athanassiou, Panagiotis, et al. "Anti-synthetase syndrome presenting with interstitial lung disease." Mediterranean journal of rheumatology vol. 28,4 (2017): 212-216. doi: https://doi.org/10.31138/mjr.28.4.212
Athanassiou P, Kostopoulos M, Tzanavari A, Spyridis A, Kostoglou-Athanassiou I. Anti-synthetase syndrome presenting with interstitial lung disease. Mediterr J Rheumatol. 2017 Dec 22;28(4):212-216. doi: 10.31138/mjr.28.4.212. eCollection 2017 Dec. PMID: 32185286; PMCID: PMC7046003.
Copy Download .nbib Format: NLM
Vitamin D levels in Greek patients with systemic lupus erythematosus.

Lupus

Athanassiou L, Kostoglou-Athanassiou I, Tsakiridis P, Devetzi E, Mavroudi M, Fytas P, Koutsilieris M, Athanassiou P.
PMID: 35006029
Lupus. 2022 Jan 10;9612033211066462. doi: 10.1177/09612033211066462. Epub 2022 Jan 10.

OBJECTIVES: Vitamin D deficiency has been observed in autoimmune rheumatic diseases, such as rheumatoid arthritis. The aim was to study vitamin D in patients with systemic lupus erythematosus (SLE) and its relationship with disease activity.METHODS: In a cohort of...

Cite
Athanassiou L, Kostoglou-Athanassiou I, Tsakiridis P, et al. Vitamin D levels in Greek patients with systemic lupus erythematosus. Lupus. 2022;9612033211066462doi: 10.1177/09612033211066462.
Athanassiou, L., Kostoglou-Athanassiou, I., Tsakiridis, P., Devetzi, E., Mavroudi, M., Fytas, P., Koutsilieris, M., & Athanassiou, P. (2022). Vitamin D levels in Greek patients with systemic lupus erythematosus. Lupus, 9612033211066462. https://doi.org/10.1177/09612033211066462
Athanassiou, Lambros, et al. "Vitamin D levels in Greek patients with systemic lupus erythematosus." Lupus vol. (2022): 9612033211066462. doi: https://doi.org/10.1177/09612033211066462
Athanassiou L, Kostoglou-Athanassiou I, Tsakiridis P, Devetzi E, Mavroudi M, Fytas P, Koutsilieris M, Athanassiou P. Vitamin D levels in Greek patients with systemic lupus erythematosus. Lupus. 2022 Jan 10;9612033211066462. doi: 10.1177/09612033211066462. Epub 2022 Jan 10. PMID: 35006029.
Copy Download .nbib Format: NLM
Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.

Blood

Psatha N, Georgakopoulou A, Li C, Nandakumar V, Georgolopoulos G, Acosta R, Paschoudi K, Nelson J, Chee D, Athanasiadou A, Kouvatsi A, Funnell APW, Lieber A, Yannaki E, Papayannopoulou T.
PMID: 34086867
Blood. 2021 Oct 28;138(17):1540-1553. doi: 10.1182/blood.2020010020.

Thalassemia or sickle cell patients with hereditary persistence of fetal hemoglobin (HbF) have an ameliorated clinical phenotype and, in some cases, can achieve transfusion independence. Inactivation via genome editing of γ-globin developmental suppressors, such as BCL11A or LRF/ZBTB7A, or...

Cite
Psatha N, Georgakopoulou A, Li C, et al. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood. 2021;138(17):1540-1553doi: 10.1182/blood.2020010020.
Psatha, N., Georgakopoulou, A., Li, C., Nandakumar, V., Georgolopoulos, G., Acosta, R., Paschoudi, K., Nelson, J., Chee, D., Athanasiadou, A., Kouvatsi, A., Funnell, A. P. W., Lieber, A., Yannaki, E., & Papayannopoulou, T. (2021). Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood, 138(17), 1540-1553. https://doi.org/10.1182/blood.2020010020
Psatha, Nikoletta, et al. "Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo." Blood vol. 138,17 (2021): 1540-1553. doi: https://doi.org/10.1182/blood.2020010020
Psatha N, Georgakopoulou A, Li C, Nandakumar V, Georgolopoulos G, Acosta R, Paschoudi K, Nelson J, Chee D, Athanasiadou A, Kouvatsi A, Funnell APW, Lieber A, Yannaki E, Papayannopoulou T. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood. 2021 Oct 28;138(17):1540-1553. doi: 10.1182/blood.2020010020. PMID: 34086867; PMCID: PMC8554647.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 54 entries